REZIPAS (AMINOSALICYLIC ACID RESIN COMPLEX) — FDA Approval NDA009052 (BRISTOL MYERS SQUIBB)
REZIPAS (AMINOSALICYLIC ACID RESIN COMPLEX) — FDA Approval NDA009052 (BRISTOL MYERS SQUIBB) is one of 9,000 drug approvals in the DrugApprovals dataset. Key details — Brand name: REZIPAS; Active ingredients: AMINOSALICYLIC ACID RESIN COMPLEX; Application number: NDA009052.
| Brand name | REZIPAS |
|---|---|
| Active ingredients | AMINOSALICYLIC ACID RESIN COMPLEX |
| Application number | NDA009052 |
| Sponsor | BRISTOL MYERS SQUIBB |
| Dosage form | POWDER |
| Route | ORAL |
| Marketing status | Discontinued |
| Products in application | 1 |
| Source | openFDA Drugs@FDA |
$1499/mo
Try DrugApprovals →